Benjamin F Hartley

Suggest Changes
Learn More
BACKGROUND The p38 MAPK pathway seems to be involved in pathogenesis of chronic obstructive pulmonary disease (COPD). Losmapimod is a potent and selective inhibitor of p38 MAPK. We assessed the(More)
  • 1